
Ian Read elected as chairman of the board at Pfizer
pharmafile | December 13, 2011 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing | Ian Read, Kindler, Pfizer
Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman.
Read succeeds George Lorch as chairman of the board, who has now been named as the its new lead independent director.
Read said: “I am deeply honoured to have been named chairman of Pfizer. Working alongside Pfizer’s dedicated leaders and talented workforce, I remain confident in the strength of our business and of our late-stage pipeline.
“I also want to thank George Lorch for his service as chairman. He has been a valuable resource and advisor this past year, and I am pleased Pfizer will continue to benefit from his active involvement on our board.”
Read took over from former chief executive Jeffrey Kindler last year after working for Pfizer’s global biopharmaceutical operations.
He joined Pfizer in 1978 and assumed positions of increasing responsibility in Latin America. In 1996, he was appointed president of Pfizer’s international pharmaceuticals group, with responsibility for Latin America and Canada.
He was named corporate VP in 2001, and assumed responsibility for Europe in addition to Canada; he later added the Africa/Middle East and Latin American regions to his leadership responsibility.
Related Content
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS
Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care …

Pfizer releases results for severe RSV-associated LRTD treatment study
US-based Pfizer have announced results from its substudy B of the ongoing phase 3 clinical …
New Real-World Data Published in Journal of Cardiac Failure on Effectiveness
Patients treated with tafamidis were associated with greater rates of survival compared with patients untreated …






